BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22348485)

  • 21. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
    Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic criteria for minimally differentiated acute myeloid leukemia (AML-M0). Evaluation and a proposal.
    Kaleem Z; White G
    Am J Clin Pathol; 2001 Jun; 115(6):876-84. PubMed ID: 11392885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometry immunophenotypic characteristics of monocytic population in acute monocytic leukemia (AML-M5), acute myelomonocytic leukemia (AML-M4), and chronic myelomonocytic leukemia (CMML).
    Gorczyca W
    Methods Cell Biol; 2004; 75():665-77. PubMed ID: 15603447
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis.
    Nomura Y; Takeuchi M; Yoshida S; Sugita Y; Niino D; Kimura Y; Shimizu K; Aoki R; Suefuji N; Hirose S; Kikuchi M; Ohshima K
    Pathol Int; 2009 Sep; 59(9):631-5. PubMed ID: 19712130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordant expression of myeloid antigens and myeloperoxidase in a case of t(8;21) positive AML expressing CD7.
    Hirai K; Torimoto Y; Moriichi K; Sato K; Ohnishi K; Taya N; Kohgo Y
    Int J Hematol; 1999 Jul; 70(1):30-5. PubMed ID: 10446492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous occurrence of myelomonocytic leukemia and multiple myeloma: involvement of common leukemic progenitors and their developmental abnormality of "lineage infidelity".
    Akashi K; Harada M; Shibuya T; Fukagawa K; Kimura N; Sagawa K; Yoshikai Y; Teshima T; Kikuchi M; Niho Y
    J Cell Physiol; 1991 Sep; 148(3):446-56. PubMed ID: 1655817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors.
    Biedermann B; Gil D; Bowen DT; Crocker PR
    Leuk Res; 2007 Feb; 31(2):211-20. PubMed ID: 16828866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
    Seshi B; Kashyap A; Bennett JM
    Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting.
    Kügler M; Stein C; Kellner C; Mentz K; Saul D; Schwenkert M; Schubert I; Singer H; Oduncu F; Stockmeyer B; Mackensen A; Fey GH
    Br J Haematol; 2010 Sep; 150(5):574-86. PubMed ID: 20636437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).
    Kotylo PK; Seo IS; Smith FO; Heerema NA; Fineberg NS; Miller K; Greene ME; Chou P; Orazi A
    Am J Clin Pathol; 2000 Feb; 113(2):193-200. PubMed ID: 10664621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunophenotype of myeloid cells in myelodysplastic syndromes and its clinical implications.
    Shao Z; Chen G; Lin Z; Zhang Y; Hao Y; Chu Y; Zheng Y; Qian L; Yang T; Yang C; Feng B
    Chin Med J (Engl); 1998 Jan; 111(1):28-31. PubMed ID: 10322648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquisition of CD13 and CD33 expression at relapse on acute myeloid leukemia cells with an unusual phenotype: MPO+CD13-CD33-.
    Kawada H; Ichikawa Y; Kobayashi N; Fukuda R; Yonekura S; Nagao T
    Intern Med; 1993 Sep; 32(9):733-6. PubMed ID: 7908235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.
    Churchill HRO; Fuda FS; Xu J; Deng M; Zhang CC; An Z; Zhang N; Chen P; Bergstrom C; Kansagra A; Collins R; John S; Koduru P; Chen W
    Cytometry B Clin Cytom; 2021 Jul; 100(4):476-487. PubMed ID: 32918786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute myelomonocytic leukemia with abnormal eosinophils: a case report with multi-modality diagnostic work-up.
    Chang ST; Hsieh YC; Lee LP; Tzeng CC; Chuang SS
    Chang Gung Med J; 2006; 29(5):532-7. PubMed ID: 17214400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance.
    Lauria F; Raspadori D; Ventura MA; Rondelli D; Testoni N; Tosi P; Michieli M; Damiani D; Motta MR; Tura S
    Stem Cells; 1995 Jul; 13(4):428-34. PubMed ID: 7549902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1993; 40(6):341-5. PubMed ID: 8289964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor.
    Riccioni R; Diverio D; Riti V; Buffolino S; Mariani G; Boe A; Cedrone M; Ottone T; Foà R; Testa U
    Br J Haematol; 2009 Feb; 144(3):376-87. PubMed ID: 19036083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.